Abstract
BackgroundSystemic sclerosis-interstitial lung disease (SSc-ILD) is a severe complication that affects most SSc patients causing one-third of SSc-related deaths [1]. There is an unmet need for predictive biomarkers of ILD...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
